Programs, populations, and payments verified via SAMHSA.
- Level of care
- IOP · MAT · Dual Dx · Telehealth
- Service settings
- Outpatient, Intensive outpatient treatment, Outpatient methadone/buprenorphine or naltrexone treatment, Regular outpatient treatment
- Therapy approaches
- Anger management, Brief intervention, Cognitive behavioral therapy, Contingency management/motivational incentives, Motivational interviewing, Matrix Model, Relapse prevention, Substance use disorder counseling
- Special populations
- Adolescents, Clients with co-occurring mental and substance use disorders, Clients who have experienced trauma
- Medications used
- Acamprosate (Campral®), Disulfiram, Buprenorphine with naloxone, Buprenorphine without naloxone, Buprenorphine (extended-release, injectable), Naltrexone (oral), Naltrexone (extended-release, injectable), Clonidine, Medication for mental disorders, Nicotine replacement + 1 more
- Recovery supports
- Assistance with obtaining social services
- Facility operation
- Private for-profit organization